Clinical Trial

Effectiveness of Aquamin® in Mitigating Halitosis

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess whether Aquamin®, a multi-mineral natural product from red marine algae, can help reduce halitosis when taken for 90 days.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2021-09-16; most recent amendment 2026-01-15.
Status change: Recruiting → Active, Not Recruiting 2025-04-25
Trial Details
NCT Number NCT05058638
Lead Sponsor University of Michigan
Conditions Healthy, Halitosis
Enrollment 15 participants
Start Date 2022-08-15
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-20